Members |
targetComponentId |
DNA från progressivt pneumonivirus hos får |
Deoxyribonucleic acid of microorganism (substance) |
DNA från Pseudorabiesvirus |
Deoxyribonucleic acid of microorganism (substance) |
DNA från Taylorella equigenitalis |
Deoxyribonucleic acid of microorganism (substance) |
DNA från Theileria mutans |
Deoxyribonucleic acid of microorganism (substance) |
DNA från Theileria parva |
Deoxyribonucleic acid of microorganism (substance) |
DNA från Trypanosoma evansi |
Deoxyribonucleic acid of microorganism (substance) |
Department of Health and Social Security (DHSS) medical examination NOS |
Specialized medical examination |
beroende av dissociativa substanser |
Hallucinogen dependence |
beroende av okänd substans |
Substance dependence (disorder) |
territorium avhängigt av Förenade kungariket Storbritannen och Nordirland |
British Overseas Territories (geographic location) |
administrering av Provera depot-injektion |
Injection of medroxyprogesterone acetate (procedure) |
administrering av depåpreventivmedel |
Administration of depot contraceptive (procedure) |
lambå från musculus depressor anguli oris |
Depressor anguli oris myocutaneous flap |
Depth of cells in anterior chamber |
Depth of anterior chamber |
Derangement of meniscus, NEC |
Derangement of meniscus |
Dermatitis atrophicans |
Acrodermatitis atrophicans chronica |
dermatit orsakad av intagen substans och/eller läkemedel |
Dermatitis caused by substance taken via oral route (disorder) |
dermatit orsakad av intagna substanser |
Dermatitis caused by substance taken via oral route (disorder) |
Dermatitis due to other specified substance taken internally |
Dermatitis caused by substance taken via oral route (disorder) |
dermatofibrom |
Dermatofibroma (morphologic abnormality) |
dermatos som kan tillskrivas antikoagulans med kumarin |
Dermatosis caused by coumarin (disorder) |
dermatos av misstänkt viral etiologi |
Suspected viral infection of skin (situation) |
dermatos orsakad av immunhämmande behandling |
Dermatosis caused by immunosuppressant |
Dermographism |
Dermatographic urticaria |
Deroofing of cyst of organ NOC |
Surgical procedure (procedure) |
flytande desfluran 99 % |
Product containing precisely desflurane 990 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
desloratadin 0,5 mg/ml, sirap |
Product containing precisely desloratadine 500 microgram/1 milliliter conventional release oral solution (clinical drug) |
desloratadin 2,5 mg/pseudoefedrin 120 mg, tablett med modifierad frisättning |
Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form) |
desloratadin 2,5 mg + pseudoefedrin 120 mg, depåtablett |
Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form) |
desloratadin 5 mg/pseudoefedrin 240 mg, tablett med modifierad frisättning |
Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form) |
desloratadin 5 mg + pseudoefedrin 240 mg, depåtablett |
Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form) |
desmoplastiskt fibrom |
Desmoplastic fibroma |
desmoplastiskt juvenilt gangliogliom |
Desmoplastic infantile astrocytoma |
desmopressinacetat 0,01 %, lösning |
Product containing only desmopressin (medicinal product) |
deoximetason 0,5 %, gel |
Product containing only desoximetasone (medicinal product) |
Destruction of intervertebral disc by other specified method |
Vertebral column destructive procedure |
Destruction of lesion of organ NOC NOS |
Destruction of lesion |
Destruction of lesion of organ NOC OS |
Destruction of lesion |
Destruction of tissue of heart |
Catheter ablation of tissue of heart |
Destruction of tissue of pharynx |
Pharynx destructive procedure |
Destructive procedure of facial bone |
Facial bone destructive procedure |
Desulfotomaculum orientis |
Desulfosporosinus orientis |
retinalavlossning i vänster öga samtidig med näthinnedefekt |
Detachment of left retina with retinal break |
retinalavlossning i höger öga samtidig med näthinnedefekt |
Detachment of right retina with retinal break |
detrusorhyperreflexi i urinblåsan |
Neurogenic detrusor overactivity |
Detrusor instability |
Idiopathic detrusor overactivity (disorder) |
Detrusor instability |
Idiopathic detrusor overactivity (disorder) |
Detrusor instability |
Idiopathic detrusor overactivity (disorder) |
blåsa med detrusorinstabilitet |
Idiopathic detrusor overactivity (disorder) |
screening för utvecklingshandikapp |
Screening for developmental disorder (procedure) |
dexametason 0,5 mg/5 ml, elixir |
Dexamethasone 100 microgram/mL oral solution |
Dexamethasone sodium phospha 0.05% |
Dexamethasone only product in ocular dose form |
dexametasonnatriumfosfat 0,05 %, ögondroppar |
Dexamethasone only product in ocular dose form |
dexametasonnatriumfosfat 0,05 %, ögondroppar för engångsbruk |
Dexamethasone only product in ocular dose form |
dexametason 0,1 % + hypromellos 0,5 %, ögondroppar |
Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution |
dexamfetamin, icke läkemedel |
Dexamfetamine |
dexlansoprazol 30 mg, depåkapsel med frisättning i två steg |
Dexlansoprazole 30 mg gastro-resistant oral capsule |
dexlansoprazol 30 mg, kapsel med modifierad frisättning |
Dexlansoprazole 30 mg gastro-resistant oral capsule |
dexlansoprazol 60 mg, depåkapsel med frisättning i två steg |
Product containing precisely dexlansoprazole 60 milligram/1 each gastro-resistant oral capsule (clinical drug) |
dexlansoprazol 60 mg, kapsel med modifierad frisättning |
Product containing precisely dexlansoprazole 60 milligram/1 each gastro-resistant oral capsule (clinical drug) |
dexmetylfenidat 20 mg, kapsel med modifierad frisättning |
Product containing precisely dexmethylphenidate hydrochloride 20 milligram/1 each prolonged-release oral capsule (clinical drug) |
dexmetylfenidat 10 mg, depåkapsel |
Product containing precisely dexmethylphenidate hydrochloride 20 milligram/1 each prolonged-release oral capsule (clinical drug) |
dexmetylfenidat 5 mg, kapsel med modifierad frisättning |
Dexmethylphenidate hydrochloride 5 mg prolonged-release oral capsule |
dexmetylfenidat 5 mg, depåkapsel |
Dexmethylphenidate hydrochloride 5 mg prolonged-release oral capsule |
dexonpatch |
Prosthetic patch |
Dexonsutur |
Polyglycolic acid suture |
dexrazoxanhydroklorid |
Product containing dexrazoxane (medicinal product) |
Dextran 40 (10%), injektionsvätska, lösning, flaska 500 ml |
Dextran 40 100 mg/mL solution for injection |
Dextran 40 10% injection |
Dextran 40 100 mg/mL solution for injection |
Dextran 40 + dextros 5 %, injektionsvätska, lösning, påse |
Dextran 40 100 mg/mL solution for injection |
Dextran 40 + natriumklorid 0,9 %, injektionsvätska, lösning, påse |
Dextran 40 100 mg/mL solution for injection |
Dextran 70 in sodium chloride 7.5% infusion |
Dextran 70 only product in parenteral dose form |
Dextran 70 i natriumklorid 7,5 %, infusionsvätska, lösning |
Dextran 70 only product in parenteral dose form |
Dextran 70 + dextros 5 %, infusionsvätska, lösning, påse |
Dextran 70 only product in parenteral dose form |
Dextran 70 + natriumklorid 0,9 %, infusionsvätska, lösning, påse |
Dextran 70 only product in parenteral dose form |
dextranallergi |
Non-allergic hypersensitivity to dextran (finding) |
dextroamfetaminsulfat 10 mg, kapsel med modifierad frisättning |
Dexamfetamine only product in oral dose form |
dextroamfetaminsulfat 10 mg, depåkapsel |
Dexamfetamine only product in oral dose form |
dextroamfetaminsulfat 15 mg, kapsel med modifierad frisättning |
Dexamfetamine only product in oral dose form |
dextroamfetaminsulfat 15 mg, depåkapsel |
Dexamfetamine only product in oral dose form |
dextroamfetaminsulfat 5 mg, kapsel med modifierad frisättning |
Dexamfetamine only product in oral dose form |
dextroamfetaminsulfat 5 mg, depåkapsel |
Dexamfetamine only product in oral dose form |
dextrometorfan 7,5 mg, pastill |
Dextromethorphan 7.5 mg oromucosal lozenge |
dextrometorfanhydrobromid 15 mg + prometazinhydroklorid 6,25 mg, vätska |
Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
dextrometorfanhydrobromid 6,67 mg/5 ml, sirap |
Dextromethorphan hydrobromide 1.33 mg/mL oral solution |
dextrometorfanhydrobromid 7,5 mg/5 ml, oralt elixir |
Product containing precisely dextromethorphan hydrobromide 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
dextrometorfanhydrobromid 7,5 mg/5 ml, sirap |
Product containing precisely dextromethorphan hydrobromide 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
dextrometorfanhydrobromidallergi |
Allergy to dextromethorphan |
Dextrose + lidocaine hydrochloride 7.5%ww/1.5%ww injection |
Lidocaine only product in parenteral dose form |
dextros 10 %, lösning |
Product containing only glucose (medicinal product) |
dextros 20 %, lösning |
Product containing only glucose (medicinal product) |
dextros 25 %, lösning |
Product containing only glucose (medicinal product) |
dextros 30 %, lösning |
Product containing only glucose (medicinal product) |
dextros 40 %, lösning |
Product containing only glucose (medicinal product) |
dextros 60 % i vatten, infusionsvätska, lösning, påse 1 000 ml |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
dextros 60 % i vatten, infusionsvätska, lösning, påse 500 ml |
Product containing precisely glucose 600 milligram/1 milliliter conventional release solution for injection (clinical drug) |
dextros 60 % i vatten, intravenös vätska, lösning, påse 1000 ml |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
dextros 60 % i vatten, intravenös vätska, lösning, påse 500 ml |
Product containing precisely glucose 600 milligram/1 milliliter conventional release solution for injection (clinical drug) |
dextros 60 %, lösning |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Dextrose 60g injection |
Product containing precisely glucose 600 milligram/1 milliliter conventional release solution for injection (clinical drug) |
dextros 7,5 viktprocent + lidokainhydroklorid 1,5 viktprocent, injektionsvätska, lösning, flaska |
Lidocaine only product in parenteral dose form |